MYC and neoplasm: We first assessed tumor growth rates in the presence of dihydroartemisinin and/or 5‐ALA in a central nervous system primitive neuroectodermal tumor (CNS‐PNET‐like) neoplasm model, which is based on the overexpression of the c‐MYC oncogene (Bian et al, 2018; Fig EV2J).